- About Us
- Guidelines
-
The Author ensures that the research has been conducted responsibly and ethically with adherence to all relevant regulations. read more..
- For Authors
- For Reviewer
- Manuscript Guidelines
- Membership
-
- Journals
- Reprints
- e-Books
- Videos
- Indexing
- Contact Us
COVID-19
- Submissions
Full Text
Forensic Science & Addiction Research
Relapses for Fun & Profit
Richard Wilmot*
San Francisco Bay, USA
*Corresponding author: Richard Wilmot, San Francisco Bay, California, USA
Submission: August 24, 2017;Published: August 30, 2018
ISSN 2578-0042 Volume4 Issue1
Opinion
Have U been here?
Many Treatment Centres are for profit! The giant corporations that own them have peered into the future and acknowledged that there is a major shift occurring as religion becomes de-sanctified and science fills the void.
With religion out and science in, the nature and favor of sin is also changing and sin is becoming addictive behavior in favor of science.
The recovery industry is doing a hostile takeover of OCD (Obsessive Compulsive Disorder) and re-branding it as ‘addiction’ so they can have their very own disease.
Such as the IPO last fall of AAC Holdings, Inc. ‒ the first attempt at a publicly traded company exclusively for addiction treatment-- (the AAC stands for American Addiction Centers).
As seen on TV
The quoted price range for a 30-day “treatment plan” (revolving largely around AA) was $15,000 to $26,000. The Hazelden Betty Ford Foundation is easily twice that amount and other, more exotic treatment facilities (often catering to celebrities in swank resort‒ style locations) can easily run into the low six‒figures.
Which reminds me:
I was talking with these two diseased people one time; one had bowel cancer and the other alcoholism.
Both were describing their relapses. The bowel cancer victim said: I have unrelenting abdominal cramping, intestinal pain and a bloody stool.
And the alcoholic said: When I relapse I get drunk, end up in bed with a woman I don’t even know and then I forget about it.
© 2018 Richard Wilmot. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and build upon your work non-commercially.
Editor In Chief
.jpg)
Signup for Newsletter
Quick Links
Editorial Board Registrations
Submit your Article
Best Paper of the Volume
Reprints
Refer a Friend
Advertise With UsOur Recent Edition
.jpg)
Top Editors
.jpg)
.bmp)
.jpg)
.png)
.jpg)
.png)
.png)
.png)
Financial Support
Sponsors
Latest e-Books
Latest Video
a Creative Commons Attribution 4.0 International License. Based on a work at www.crimsonpublishers.com.
Best viewed in 
| Above IE 9.0 version